Abstract
Bioprinting facilitates the generation of complex, three-dimensional (3D), cell-based constructs for various applications. Although multiple bioprinting technologies have been developed, extrusion-based systems have become the dominant technology due to the diversity of materials (bioinks) that can be utilized, either individually or in combination. However, each bioink has unique material properties and extrusion characteristics that affect bioprinting utility, accuracy, and precision. Here, we have extended our previous work to achieve high precision (i.e., repeatability) and printability across samples by optimizing bioink-specific printing parameters. Specifically, we hypothesized that a Fuzzy Inference System (FIS) could be used as a computational method to address the imprecision in 3D bioprinting test data and uncover the optimal printing parameters for a specific bioink that result in high accuracy and precision. To test this hypothesis, we have implemented a FIS model consisting of four inputs (bioink concentration, printing flowrate, speed, and temperature) and two outputs to quantify the precision (scaffold bioprinted linewidth variance) and printability. We validate our use of the bioprinting precision index (BPI) with both standard and normalized printability factors. Finally, we utilize optimized printing parameters to bioprint scaffolds containing up to 30 × 106 cells/mL with high printability and precision. In total, our results indicate that computational methods are a cost-efficient measure to improve the precision and robustness of extrusion 3D bioprinting with gelatin-based bioinks.
Keywords: Extrusion Bioprinting, Fuzzy System, Gelatin, Approximation, Printability, Precision
1. Introduction:
1.1. Bioprinting
Additive manufacturing is a process by which three-dimensional objects are generated by depositing material in sequential layers [1–3]. Bioprinting is an emerging field of additive manufacturing, in which bioactive scaffolds can be quickly generated by depositing layers of cell-laden biocompatible materials, such as collagen or other hydrogels [4]. After slicing a computational three-dimensional (3D) model of a desired scaffold, the appropriate extrusion path and required printing parameters can be used to direct the fabrication of the construct in a layer-by-layer fashion. Indeed, the ability to place cells in biologically relevant scaffold materials with a high spatial resolution has made bioprinting a popular fabrication method for tissue engineering [4–6].
However, the parameters used to perform the bioprinting procedure will have significant effects on the final properties of the scaffold [7]. Therefore, it is essential to fully characterize and optimize the bioprinting parameters (e.g., print speed or bioink viscosity) necessary to reach the desired outputs, such as architectural matching of the defect shape, high cell viability, appropriate cell function, and mechanical properties [8]. For example, increasing the nozzle size on the bioprinter decreases the shear stress placed on the biomaterial during extrusion, resulting in increased cell viability but reduced print resolution [9]. Therefore, determining the optimal print parameters is imperative for success in bioprinting. As a result, several studies have been performed in the field of bioprinting optimization, such as the optimization of a computational model for 3D bioprinting, bioink optimization, and bioprinting parameter selection [10,11].
Hydrogels provide three-dimensional (3D) support for cellular growth and tissue formation similar to native extracellular matrix (ECM) and are widely utilized to study cellular proliferation, migration, differentiation, and interaction [12–14]. In general, hydrogels are crosslinked networks of hydrophilic polymers that swell in water [13,15,16]. One of the most common natural hydrogels in biomedical applications and bioprinting is gelatin, which is derived through collagen hydrolysis. Although there are several ways to hydrolyze the collagen, we have used Type A (acid-derived) gelatin in this experiment. Gelatin is particularly useful for drug release and tissue engineering due to its biocompatibility [17], rapid biodegradability, constituent purity, high cell attachments due to arginine-glycine-aspartic acid (RGD) sequences [18], and tunable physical properties [16]. The composition, crosslinking method, and level of crosslinking of gelatin-based materials affect its physical and biochemical properties. Crosslinking gelatin bioink can be done by photo crosslinking [7,19], enzymatic crosslinking [20], thermal crosslinking [21], or chemical crosslinking [22]. As a result, our study is directly applicable to a variety of other gelatin-based bioinks, such as gelatin methacryloyl (GelMA) [13,23].
1.2. Approximation and Prediction
There is a significant degree of imprecision and uncertainty inherent in bioprinting optimization. A potential approach to handling this issue, which arises from normal biological variation, is implementing approximation systems based on computational methods [24]. In recent years, systems biology has become a critical multidisciplinary research area between computer science and biology. Studies in this field aim to develop computational models of biological processes, requiring both a robust dynamic model and a large dataset of experimental results [25,26].
Developing a dynamic model is challenging and requires well-characterized control parameters to approximate laboratory experiments’ outcomes. Nonetheless, recent studies have observed that machine learning algorithms can effectively predict output parameters using either a deterministic or stochastic biological model. A partial list of the approaches employed to this end includes meta-heuristic, evolutionary, global optimization, genetic programming, simulated annealing, simplex, ant-colony, fuzzy genetic hybrid system, and multi-objective optimization [25,27]. In-silico models have significantly helped reproducibility and quality in the in-vitro experiments in tissue engineering fields [28–30].
1.3. Fuzzy Inference System (FIS)
Fuzzy Logic (FL) is an extension of standard logic, in which values can only be completely false or completely true. In contrast to the standard logic set with a crisp boundary, values in the Fuzzy set can have a degree of truth between 0 (completely false) and 1 (completely true) [31]. Moving from discrete to continuous values provided a computational approach to approximate the model output with the inherited uncertainty and imprecision. As a result, this status offers a computational model to move from discrete to continuous values. A system based on FL is called a Fuzzy Inference System (FIS). A FIS is a framework consisting of Fuzzification, Inference Engine, and Defuzzification. A complete discussion of the Fuzzy Set theory and implementation can be found in the Supplement.
As a potential solution for overcoming potential uncertainty, we have developed a quantitative model of a biomanufacturing process using the FIS approach. Previous studies have shown that the accuracy of a fuzzy system approach is the same as the deterministic mathematical approach (ordinary differential equations) for the same kinetic dataset [32]. Moreover, fuzzy systems can be utilized to find a qualitative system response when a quantitative dataset is unavailable [31,33]. In decision-making systems, theoretical fuzzy models have been used to approximate biomechanical properties such as the stress/strain of a bone structure in a biological process [34–36]. The mathematical model of the FIS has been provided in the Supplement.
1.4. Approximation in 3D printed Scaffold
Bioprinting outputs can be predicted using classic physics formulation or computational and machine learning methods. We recently demonstrated that computational methods are precise in the output approximation, which can be measured and optimized based on the bioprinting inputs of speed, pressure, and dilution percentage [34]. Here, we propose to implement an approximation model using a 3D scaffold with greater complexity of inputs. To do so, we implemented a fuzzy system and measured the approximation error on the dataset. Ultimately, we optimized and approximated the bioprinting output for extrusion parameters in four different precision and printability indexes and measured the validation error. Fig. 1 shows the general workflow of the process.
2. Methods
2.1. Bioprinting parameters and study design
Gelatin was chosen as a bioink for acellular 3D printing and bioprinting due to its ability to form hydrogel constructs of similar stiffness to soft tissue as well as permit adequate cellular proliferation and differentiation [14,37]. Here, we refer to both acellular and cellular gelatin as bioink. Importantly, gelatin is a highly temperature-dependent material whose viscosity generally decreases as a function of temperature and concentration [38]. Therefore, optimization of gelatin concentrations and bioink temperature is critical for achieving high-precision bioprinting. Furthermore, the extrusion flow rate (corollary to the input voltage to the extrusion motor) and travel speed of the nozzle strongly affects printing precision. To investigate the effect of these four factors (gelatin concentration, bioink temperature, flow rate, and nozzle speed) on the precision and printability of gelatin, a full factorial design (all possible combinations) is the most reliable experimental design. However, this method is not practical in terms of time and cost due to the large number of experiments required. Therefore, we utilized a common experimental design to identify the minimum number of experiments required, known as response surface methodology (RSM) [39]. Specifically, we used a central composite design (CCD) in which the center points have enough replication to allow for a test of the model’s lack of fit. Here, our input parameters were designed to span the range of optimal values as follows: the input voltage of the extrusion motor (0.9, 1.1, and 1.3 V), travel speed of the nozzle (4, 8, and 12 mm/s), bioink temperature (15, 25, and 35 °C), and bioink concentration (3, 4, and 5% w/v). Since each parameter had three discrete values, the number of experiments required to provide FIS input data was 31 prints including 7 center points (Table 1). Each print condition was performed in triplicate.
Table 1.
Order | Gelatin bioink Conc. (W/V%) | Printing Speed (mm/s) | Flow Rate (V) | Bioink Temperature (°C) | Experimental (Input) Data (Output) | FIS Approximation (Output) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Printability | Categorized | Precision | Categorized | Printability | Categorized | Precision | Categorized | |||||
1 | 4 | 8 | 1.1 | 15 | 0.4 | L | 292 | L | 0.3248 | L | 199 | H |
2 | 4 | 8 | 0.9 | 25 | 1 | H | 135 | H | 0.8717 | H | 142 | H |
3 | 4 | 8 | 1.1 | 25 | 1 | H | 128 | H | 0.8717 | H | 142 | H |
4 | 4 | 8 | 1.1 | 25 | 1 | H | 241 | H | 0.8717 | H | 142 | H |
5 | 4 | 8 | 1.1 | 25 | 0.8 | L | 145 | H | 0.8717 | H | 142 | H |
6 | 4 | 8 | 1.1 | 25 | 1 | H | 240 | H | 0.8717 | H | 142 | H |
7 | 4 | 8 | 1.1 | 25 | 1 | H | 207 | H | 0.8717 | H | 142 | H |
8 | 4 | 8 | 1.1 | 25 | 1 | H | 161 | H | 0.8717 | H | 142 | H |
9 | 4 | 8 | 1.1 | 25 | 0.84 | H | 182 | H | 0.8717 | H | 142 | H |
10 | 4 | 8 | 1.3 | 25 | 0.95 | H | 144 | H | 0.8717 | H | 142 | H |
11 | 4 | 12 | 1.1 | 25 | 1 | H | 101 | H | 0.8716 | H | 142 | H |
12 | 4 | 4 | 1.1 | 25 | 0.9 | H | 152 | H | 0.8716 | H | 142 | H |
13 | 4 | 8 | 1.1 | 35 | 0.82 | H | 199 | H | 0.8717 | H | 142 | H |
14 | 3 | 4 | 1.3 | 15 | 1 | H | 350 | L | 0.8716 | H | 255 | L |
15 | 3 | 12 | 1.3 | 15 | 0.13 | L | 305 | L | 0.3284 | L | 255 | L |
16 | 3 | 4 | 0.9 | 15 | 0.31 | L | 149 | H | 0.3284 | L | 202 | H |
17 | 3 | 12 | 0.9 | 15 | 0.05 | L | 258 | L | 0.3284 | L | 250 | L |
18 | 3 | 8 | 1.1 | 25 | 1 | H | 160 | H | 0.8717 | H | 142 | H |
19 | 3 | 12 | 0.9 | 35 | 0.4 | L | 216 | H | 0.3284 | L | 140 | H |
20 | 3 | 12 | 1.3 | 35 | 0.17 | L | 456 | L | 0.3284 | L | 255 | L |
21 | 3 | 4 | 0.9 | 35 | 0.45 | L | 234 | H | 0.3284 | L | 140 | H |
22 | 3 | 4 | 1.3 | 35 | 0.12 | L | 437 | L | 0.3284 | L | 255 | L |
23 | 5 | 4 | 0.9 | 15 | 0.18 | L | 263 | L | 0.3284 | L | 250 | L |
24 | 5 | 12 | 1.3 | 15 | 0.12 | L | 249 | H | 0.3284 | L | 140 | H |
25 | 5 | 4 | 1.3 | 15 | 0.67 | L | 496 | L | 0.6 | L | 255 | L |
26 | 5 | 12 | 0.9 | 15 | Not printed | |||||||
27 | 5 | 8 | 1.1 | 25 | 1 | H | 225 | H | 0.8717 | H | 142 | H |
28 | 5 | 12 | 0.9 | 35 | 0.6 | L | 188 | H | 0.6 | L | 140 | H |
29 | 5 | 4 | 1.3 | 35 | 0.66 | L | 385 | L | 0.6 | L | 255 | L |
30 | 5 | 4 | 0.9 | 35 | 0.22 | L | 171 | H | 0.328 | L | 140 | H |
31 | 5 | 12 | 1.3 | 35 | 0.35 | L | 396 | L | 0.3284 | L | 255 | L |
2.2. Acellular 3D bioprinting
Three different concentrations of ink (3%, 4%, and 5% w/v) were prepared and stored in 50 mL centrifuge tubes. Type A gelatin from porcine skin (gel strength 300, G2500-500G, Sigma-Aldrich) was measured and gradually added to warmed Dulbecco’s phosphate-buffered saline (DPBS) (Gibco 14190136). For better contrast during the imaging, 100 μL of red food dye was added to each solution. Next, 2.5 mL of each gelatin ink concentration was pipetted into a 3 mL syringe. The syringe was capped with a 25-gauge 0.25 mm internal diameter tapered plastic tip nozzle (8001279, Fisnar), and the syringe was loaded into a custom-built extrusion bioprinter with a temperature control system. The extrusion of the biomaterial was controlled via voltage delivered to a 6V 30:1 micromotor with a threaded shaft (Pololu). The print layout was a 30 mm × 30 mm grid square with a 500 μm layer height. Infill distances were 5 mm. Three replicates of each printing parameter set were performed (n=3). Each freshly loaded ink syringe was maintained for ten minutes in a water bath inside a 4 °C fridge. Then, the syringe was put in the preheated bioprinter extruder and kept at the printing temperature for at least 10 minutes before printing. Room humidity was maintained at less than 40% with a room temperature range of 22–24 °C. Constructs were imaged using a stereo microscope (LAXCOTM) at 0.67X zoom and analyzed in FIJI [21].
2.3. Gaussian (nominal) Distribution Analysis
To determine and quantify the actual bioprinted construct line width, we measured each side of the 16 squares (40 data points per sample). In order to implement the FIS with our measured data series for each printed scaffold, we used a nominal distribution to find the variance for the linewidth data for each printing parameter. Here, low variance indicates a more uniform line width data in a printed scaffold. Therefore, our approximator used the variance as a precision measurement (the first output). The Gaussian distribution is a two-parameter family of curves, which is a continuous probability distribution for a real-valued random variable. The general form of the normal probability density function (pdf) is:
Where is the mean and is the variance.
2.4. Printability Factor
Printability is a factor that quantifies shape fidelity with a referenced formula for multiple shapes. For a square shape, the bioink printability () uses the following function:
Where is the perimeter and is the area of the enclosed area. For an ideal gelation condition or perfect printability status, the interconnected channels of the constructs would demonstrate a square shape, and the value is 1. indicates the degree of gelatin bioink to maintain the construct shape fidelity [40]. Although a shape can have the value equivalent to 1, this metric does not represent the overall 3D construct shape fidelity. Therefore, we introduced a new metric generated by multiplying by the normalization coefficient. We use the following normalization coefficient to normalize the value:
Here, we expected 16 squares in each printed scaffold. In this approximation model, is the second system output.
2.5. Fuzzy Inference System
The FIS structure is programmed utilizing the MATLAB FIS editor toolbox to implement the model and approximate the precision and printability. The Sugeno-based fuzzy inference system and the Gaussian membership functions are used to fuzzify the datasets and map the relationship between the process inputs and the outputs. In the first step, we designed FIS membership functions with four inputs (gelatin concentration (% w/v), bioink temperature (°C), flowrate (V), speed (mm/s)), and two outputs (precision and printability) (Supplemental Figure 1). The detailed implemented FIS also includes the inputs, fuzzifier, rules, inference engine, defuzzifier, and outputs (Fig. 2). The implemented fuzzy rules are detailed in the Supplemental Methods. Next, we measured the Root Mean Square Error (RMSE) and accuracy between the experimented output (precision and printability) and the approximated outputs.
The approximation RMSE is calculated based on the error between the actual (printed) precision for a printing set and the approximated for each print set as follows:
Where is the number of observations (printed scaffolds Table 1–2). The accuracy of the FIS on given datasets is derived as follows:
Table 2.
Order | Gelatin bioink Conc. (W/V%) | Printing Speed (mm/s) | Flow Rate (V) | Bioink Temperature (C) | Validation Data FIS Approximation | Validation Data Experimental Result | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Printability | Categorized | Precision | Categorized | CP | Printability | Categorized | Precision | Categorized | |||||
Group A) High Printability, High Precision | |||||||||||||
V 7 | 4 | 6 | 0.9 | 30 | 0.82 | H | 150 | H | 9.3 | 0.7 | L | 155 | H |
V 14 | 3 | 8 | 1 | 30 | 0.82 | H | 150 | H | 12.8 | 0.93 | H | 178 | H |
V 8 | 4 | 6 | 1 | 30 | 0.82 | H | 150 | H | 4 | 0.85 | H | 164 | H |
V 5 | 5 | 8 | 1 | 30 | 0.82 | H | 150 | H | 12.8 | 0.85 | H | 170 | H |
Group B) Low Printability, High Precision | |||||||||||||
V 1 | 5 | 12 | 1.2 | 15 | 0.37 | L | 150 | H | 43 | 0.12 | L | 231 | H |
V 16 | 3 | 6 | 0.9 | 35 | 0.37 | L | 150 | H | 13.2 | 0.7 | L | 238 | H |
V 6 | 5 | 6 | 0.9 | 35 | 0.37 | L | 150 | H | 13 | 0.87 | H | 201 | H |
V 15 | 3 | 12 | 1 | 30 | 0.37 | L | 150 | H | 44 | 0.8 | L | 220 | H |
Group C) High printability, Low Precision | |||||||||||||
V 9 | 3 | 4 | 1.2 | 15 | 0.85 | H | 255 | L | 61 | 0.95 | H | 434 | L |
V 10 | 3 | 6 | 1.3 | 15 | 0.85 | H | 255 | L | 45 | 0.66 | H | 421 | L |
V 12 | 3 | 4 | 1.3 | 20 | 0.85 | H | 255 | L | 45.7 | 0.96 | H | 192 | H |
V 3 | 5 | 8 | 1.3 | 25 | 0.85 | H | 255 | L | 72.6 | 1 | H | 245 | H |
Group D) Low Printability, Low Precision | |||||||||||||
V 2 | 3 | 10 | 1.3 | 30 | 0.37 | L | 255 | L | 116 | 0.95 | H | 548 | L |
V 13 | 5 | 6 | 0.9 | 20 | 0.37 | L | 255 | L | 88.4 | 0.3 | L | 292 | L |
V 11 | 3 | 12 | 1 | 15 | 0.37 | L | 255 | L | 58 | 0.36 | L | 300 | L |
V 4 | 5 | 12 | 1.2 | 30 | 0.37 | L | 255 | L | 116 | 0.85 | H | 293 | L |
2.6. Bioprinting Precision Index
In recent work, we introduced the Bioink Precision Index (BPI) as a new metric for evaluating bioink precision [34]. BPI is a metric derived from a fuzzy surface gradient value (e.g. Fig. 4); therefore, this metric is dimensionless to measure precision and system robustness. Furthermore, this technique can be applied to the printing of any 2D or 3D shape. In contrast to our previous work, we applied this method to a 3D shape (scaffold) to approximate the printability and precision to optimize and achieve the BPI.
The standard calculation for a gradient of a 3D surface with four inputs:
Thus, BPI is calculated from the sum of the squared error of the above equation:
Where , , , and are the inputs in our system (gelatin concentration, flowrate, speed, and temperature).
2.7. Cell Culture
C2C12 immortalized mouse myoblasts (CRL-1772TM, ATCC) were cultured in T75 and T175 flasks with proliferation medium: Dulbecco’s Modified Eagle Medium, high glucose, pyruvate (Gibco, 11995-081); qualified, heat-inactivated fetal bovine serum (Gibco, 16140-071) at 10% (v/v); and penicillin-streptomycin (Gibco, 15070-063) at 1% (v/v). When the cells reached above 80% confluency, they were suspended using a 0.05% of Trypsin-EDTA solution (Gibco, 15400054), diluted in DPBS, and reseeded into a new flask at an appropriate seeding density to enable cell expansion. Once an adequate number of cells were generated, the cells were again suspended, counted, and encapsulated in the gelatin bioink warmed to 37 °C at concentrations of 1, 10, and 30×106 cells/mL for rheological and cell printing tests.
2.8. Bioink rheological testing
The viscosities of the 4% (w/v) gelatin bioinks at concentrations of 1, 10, and 30×106 cells/mL were evaluated using a Discovery Hybrid Rheometer-3 (TA Instruments). The system was controlled using TRIOS software. Each of the bioinks at varying cell concentrations was tested by pipetting 1.9 mL of the bioink onto the testing surface and a 60 mm flat parallel plate testing geometry (511600.905, TA Instruments) was lowered to a testing gap of 600 μm. The top bowl of the parallel plate geometry was filled with distilled water and enclosed with a solvent trap to prevent evaporation of the hydrogel. The sample was heated to 37 °C and preshear was performed at a rate of 100 1/s for 60 s. The material was allowed to stabilize by cooling the sample to 4 °C and then warming the sample to 30 °C for 10 min. The viscosity was measured by flow sweep with a shear rate range of 1–333 1/s collecting 10 points per decade.
2.9. Cellular 3D bioprinting
Bioinks consisting of cellular concentrations of 1, 10, and 30 × 106 cells/mL in 4% (w/v) gelatin were loaded into 3 mL syringes and bioprinted as described using the same printing geometry. However, no food dye was added to these bioinks. The printing parameter set was predicted by the model to exhibit high printability and high precision: a temperature of 30 °C, extrusion voltage of 0.9, and speed of 6 mm/s. The macroscopic scaffold was again captured using a stereo microscope. Magnified phase-contrast images to display the varying cell densities were captured on an Axio Observer 7 microscope (Zeiss).
3. Results
3.1. FIS Approximator Performance
First, the series of parameter sets designed to function as the FIS input data (Table 1) were used for bioprinting and the resultant constructs were imaged. Next, printing precision and printability were quantified for each parameter set. Printability values over 0.8 and precision values lower than 250 were categorized as “high”. Conversely, printability factors equal and less than 0.8 and precision over 250 were categorized as “low”. As a result, the parameter sets could be divided into four groups: A) high precision, high printability; B) high precision, low printability; C) low precision, high printability; and D) low precision, low printability (Fig. 3). Overall, we observed that the FIS approximated the experimental input data with 95% accuracy and low relative RMSE for both precision (92.9) and printability (0.12) outputs (Table 3).
Table 3.
Printability | Precision | |||
---|---|---|---|---|
RMSE | Accuracy | RMSE | Accuracy | |
FIS Input Dataset | 0.12 | 95% | 92.9 | 95% |
Validation Dataset | 0.28 | 75% | 105.3 | 87% |
3.2. FIS Validation
Next, we used six BPI surfaces to visualize the results of the multi-dimensional FIS approximation, considering either precision as an output (Fig. 4a) or printability as an output (Fig. 4b). To validate this model for approximating and optimizing precision and printability, we randomly chose three printing parameter sets to represent each of the four groups characterized previously (Table 2). Importantly, these validation parameter sets were not included in the parameter sets used to generate the FIS input data. Each validation parameter set was used to generate three individual constructs using the same conditions as the FIS input data (Fig. 5). Here, the printability and precision validation accuracy was 75% and 87%, respectively. Furthermore, the RMSE value for printability and precision with the validation dataset was 0.28 and 105.3 (Table 3).
In general, the printed constructs were consistent with our model approximations (Fig. 5). In particular, the mean precision (166 ± 9.7) and printability (0.8 ± 0.09) in Group A were both categorized as high, and resulted in continuous, uniform fibers with little bleeding of the deposited filament. Similarly, the results from Group B were as predicted, with mean printability categorized as low (0.6 ± 0.3) and mean precision categorized as high (222.5 ± 16.13). Here, the resultant printed constructs had relatively uniform fibers with discontinuous filaments or non-sharp corners. In Group C, the results were consistent with the approximated data and categorized as high mean printability (0.89 ± 0.15) and low mean precision (323 ± 122). Group C printed constructs exhibited relatively continuous fibers with good intersections in most groups, but the prints were often over-gelated with inconsistent fibers, jagged edges, discontinuities, and various diameters. Finally, the results from Group D were categorized as low mean printability (0.6 ± 0.3) and low mean precision (358 ± 126), consistent with model predictions. Thus, Group D constructs had highly variable diameters and discontinuous fibers that were too fluid and bled into each other.
3.3. Cell-laden bioink
Finally, we analyzed bioink viscosity following the inclusion of cells of varying concentration into a 4% (w/v) gelatin bioink (Fig. 6A). The viscosity of the bioink at 30 °C was similar across cellular concentrations from 0, 1, 10, and 30 × 106 cells/mL. During the constant portion of the viscosity curve, the bioink containing 30 × 106 cells/mL did exhibit a modest increase in viscosity that is unlikely to affect bioprinting outcomes. Next, cell-laden gelatin bioinks were bioprinted using parameter sets predicted to have high precision and printability: 4% (w/v), 30 °C, 0.9 V, and 6 mm/s (Fig. 6B). Here, we observed results from all cell concentrations were similar to the acellular prints. The varying cell densities of the bioprinted fibers were confirmed using phase contrast microscopy (Fig. 6C).
4. Discussion
In this study, we introduced a novel approach to approximate the Bioink Precision Index (BPI) by utilizing a fuzzy inference system (FIS) in a 3D bioprinting process with multiple inputs and outputs. In this model, inputs included gelatin bioink concentration, bioprinting flowrate, printing speed, and bioink temperature along with two outputs (precision and printability). Next, the BPI surface was generated using the experimental design data. We then tested four new printing parameter sets that had not been in the FIS input dataset. As expected, the precision and printability of the constructs varied widely based on the parameter set. Importantly, the experimental results were consistent with the approximation model that accurately predicted parameter sets with both high and low precision. Finally, we utilized the optimal printing parameters to generate high-precision constructs with cell-laden bioink. In total, our study demonstrates that computational methods are a cost-effective way to significantly improve precision in 3D bioprinting.
The difference between fuzzy systems and machine learning methods, such as neural networks, is that fuzzy systems can utilize raw and ambiguous data whereas neural networks rely on training data to learn and improve system accuracy over time. Moreover, fuzzy systems have transparency in data inferencing and approximation, whereas the inference model used with machine learning methods cannot be precisely extracted. Therefore, we used an FIS model to robustly approximate precision and printability in gelatin-based bioprinting. Nonetheless, we note that this system can be adapted to essentially any bioink or bioprinting environment. In contrast, conventional physics-based formulations cannot be utilized for optimization since they are not reversible in the multi-parameter domain. Also, the non-convex solution space and discrete values in the traditional formulation of the process decrease the probability of obtaining optimized bioprinting parameter sets.
One of the limitations of this study is the lack of experiments using alternative nozzle sizes. Furthermore, since the BPI is specifically a measure of output precision, utilizing a parameter set with optimal BPI may not result in high accuracy. As a result, choosing a parameter set for bioprinting may result in a necessary tradeoff between accuracy and precision. Furthermore, future work could extend this approach to other parameters that bioprinting experimental outcomes, such as cell viability or biocompatibility. Nonetheless, we note that BPI is independent of input dimensions/units and will remain a valuable metric as bioprinting needs and technology evolves.
To ensure that our optimization of printing parameters extended to cell-laden bioink, we bioprinted gelatin containing C2C12 myoblasts in a range of common cell densities. Indeed, previous work identified 30 × 106 cells/mL to be the most effective concentration of cells for direct implantation and differentiation of skeletal muscle cells [41]. Importantly, the inclusion of cells did not dramatically change the viscosity of the bioink across any of the tested cell concentrations. While a 1–2 kPa.s increase in viscosity was noticed for the 30 M cells/mL, we do not expect that this modest effect would have any impact on bioprinting. Indeed, previous studies demonstrated that cell concentrations under a 40% volume fraction do not induce changes in viscosity that affect bioprinting; 30 × 106 cells/mL is well under a 40% volume fraction [42,43]. Furthermore, we found that optimized parameter sets resulted in similar bioprinted constructs utilizing bioink with or without cells. In total, experimental validation of our optimization method using cell-laden bioink increases the impact of this work by demonstrating that optimization of bioprinting parameters can be performed without cells and their associated costs.
5. Conclusion
Obtaining high precision in bioprinting is a necessary step toward the mass production of bioprinted 3D constructs for use in research and medicine. Here, we have demonstrated that the Fuzzy Inference System (FIS) approach can be used to approximate output precision and printability with a set of bioprinting parameters, including printing speed, flowrate, gelatin bioink concentration, and bioink temperature, as well as determine bioprinting parameter sets that maximize precision in 3D constructs. Furthermore, we have applied the previously defined Bioink Precision Index (BPI) that can be used to quickly compare the ease of reproducibility regardless of the number of inputs, and environment.
Supplementary Material
Acknowledgment
This research is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award numbers AR074953 (RET) and DE028397 (RET). Other financial support from the National Institutes of Health (AR077132, AR073822, AR079114) is gratefully acknowledged. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding bodies.
Footnotes
Conflict of interest
Authors have no competing interests to declare.
References:
- 1.Sedigh A, Kachooei AR, Beredjiklian PK, Vaccaro AR, Rivlin M. Safety and efficacy of casting during COVID-19 pandemic: A comparison of the mechanical properties of polymers used for 3D printing to conventional materials used for the generation of orthopaedic orthoses. Arch Bone Jt Surg. 2020;8(SpecialIssue). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sedigh A, Ebrahimzadeh MH, Zohoori M, Kachooei A. Cubitus Varus Corrective Osteotomy and Graft Fashioning Using Computer Simulated Bone Reconstruction and Custom-Made Cutting Guides. Arch Bone Jt Surg [Internet]. 2020. Nov 15 [cited 2020 Dec 15];0. Available from: https://abjs.mums.ac.ir/article_17009.html [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.SEDIGH A, KACHOOEI AR, VACCARO AR, RIVLIN M. Contactless Remote 3D Splinting during COVID-19: Report of Two Patients. 10.1142/S2424835522720171. 2022. Apr 19;27(02):398–402. [DOI] [PubMed] [Google Scholar]
- 4.Ghelich P, Kazemzadeh-Narbat M, Najafabadi AH, Samandari M, Memíc AM, Tamayol A. (Bio)manufactured Solutions for Treatment of Bone Defects with an Emphasis on US-FDA Regulatory Science Perspective. Adv NanoBiomed Res [Internet]. 2022. Apr 1 [cited 2022 Jul 7];2(4):2100073. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/anbr.202100073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Derakhshanfar S, Mbeleck R, xu K, Zhang x, Zhong W, xing M. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Vol. 3, Bioactive Materials. KeAi Communications Co.; 2018. p. 144–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Murphy S V, Atala A 3D bioprinting of tissues and organs [Internet]. Vol. 32, Nature Biotechnology. Nature Publishing Group; 2014. [cited 2020 Sep 7]. p. 773–85. Available from: https://pubmed.ncbi.nlm.nih.gov/25093879/ [DOI] [PubMed] [Google Scholar]
- 7.Samandari M, Mostafavi A, Quint J, Memić A, Tamayol A. In situ bioprinting: intraoperative implementation of regenerative medicine. Trends Biotechnol [Internet]. 2022. Apr [cited 2022 May 21]; Available from: https://pubmed.ncbi.nlm.nih.gov/35483990/ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med [Internet]. 2016. Jun [cited 2019 Sep 4];15(2):155–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27330520 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Webb B, Doyle BJ. Parameter optimization for 3D bioprinting of hydrogels. Bioprinting. 2017. Dec 1;8:8–12. [Google Scholar]
- 10.Sedigh A, Tulipan JE, Rivlin MR, Tomlinson RE. Utilizing Q-Learning to Generate 3D Vascular Networks for Bioprinting Bone. bioRxiv [Internet]. 2020. Oct 8 [cited 2020 Oct 18];2020.10.08.331611. Available from: 10.1101/2020.10.08.331611 [DOI] [Google Scholar]
- 11.Suntornnond R, Tan E, An J, Chua C. A Mathematical Model on the Resolution of Extrusion Bioprinting for the Development of New Bioinks. Materials (Basel) [Internet]. 2016. Sep 6 [cited 2020 Oct 18];9(9):756. Available from: http://www.mdpi.com/1996-1944/9/9/756 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Annabi N, Tamayol A, Uquillas JA, Akbari M, Bertassoni LE, Cha C, et al. 25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater [Internet]. 2014. Jan 8 [cited 2022 May 21];26(1):85–124. Available from: https://pubmed.ncbi.nlm.nih.gov/24741694/ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials [Internet]. 2015. Dec 1 [cited 2022 May 21];73:254–71. Available from: https://pubmed.ncbi.nlm.nih.gov/26414409/ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Quint JP, Samandari M, Abbasi L, Mollocana E, Rinoldi C, Mostafavi A, et al. Nanoengineered myogenic scaffolds for skeletal muscle tissue engineering. Nanoscale [Internet]. 2022. Jan 20 [cited 2022 May 21];14(3):797–814. Available from: https://pubs.rsc.org/en/content/articlehtml/2022/nr/d1nr06143g [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ghelich P, Salehi Z, Mohajerzedeh S, Jafarkhani M. Experimental and numerical study on a novel microfluidic method to fabricate curcumin loaded calcium alginate microfibres. Can J Chem Eng [Internet]. 2018. Nov 1 [cited 2022 May 21];96(11):2342–51. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/cjce.23173 [Google Scholar]
- 16.Samandari M, Quint J, Rodríguez-delaRosa A, Sinha I, Pourquié O, Tamayol A. Bioinks and Bioprinting Strategies for Skeletal Muscle Tissue Engineering. Adv Mater [Internet]. 2022. Mar 1 [cited 2022 May 21];34(12):2105883. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/adma.202105883 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nuutila K, Samandari M, Endo Y, Zhang Y, Quint J, Schmidt TA, et al. In vivo printing of growth factor-eluting adhesive scaffolds improves wound healing. Bioact Mater [Internet]. 2022. Feb 1 [cited 2022 May 21];8:296. Available from: /pmc/articles/PMC8427093/ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Liu Y, Chan-Park MB. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. Biomaterials [Internet]. 2010Feb [cited 2022 May 21];31(6):1158–70. Available from: https://pubmed.ncbi.nlm.nih.gov/19897239/ [DOI] [PubMed] [Google Scholar]
- 19.Naseer SM, Manbachi A, Samandari M, Walch P, Gao Y, Zhang YS, et al. Surface acoustic waves induced micropatterning of cells in gelatin methacryloyl (GelMA) hydrogels. Biofabrication [Internet]. 2017. Mar 1 [cited 2022 May 21];9(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28195834/ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.DEGRAEVE P, SABAGHI M, JOLY C, ADT I, OZTURK K, COTTAZ A. Effect of Crosslinking by Microbial Transglutaminase of Gelatin Films on Lysozyme Kinetics of Release in Food Simulants. SSRN Electron J [Internet]. 2022. [cited 2022 May 21]; Available from: https://papers.ssrn.com/abstract=4067176 [Google Scholar]
- 21.Gungor M, Sagirli MN, Calisir MD, Selcuk S, Kilic A. Developing centrifugal spun thermally cross-linked gelatin based fibrous biomats for antibacterial wound dressing applications. Polym Eng Sci [Internet]. 2021. Sep 1 [cited 2022 May 21];61(9):2311–22. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/pen.25759 [Google Scholar]
- 22.Hennink WE, Van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev [Internet]. 2002. Jan 17 [cited 2022 May 21];54(1):13–36. Available from: https://pubmed.ncbi.nlm.nih.gov/11755704/ [DOI] [PubMed] [Google Scholar]
- 23.Quint JP, Mostafavi A, Endo Y, Panayi A, Russell CS, Nourmahnad A, et al. In Vivo Printing of Nanoenabled Scaffolds for the Treatment of Skeletal Muscle Injuries. Adv Healthc Mater [Internet]. 2021. May 1 [cited 2022 Jul 7];10(10):2002152. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.202002152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Torres A, Nieto JJ. Fuzzy logic in medicine and bioinformatics. Vol. 2006, Journal of Biomedicine and Biotechnology. 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sun J, Garibaldi JM, Hodgman C. Parameter estimation using metaheuristics in systems biology: A comprehensive review. IEEE/ACM Trans Comput Biol Bioinforma [Internet]. 2012. [cited 2021 Mar 26];9(1):185–202. Available from: https://pubmed.ncbi.nlm.nih.gov/21464505/ [DOI] [PubMed] [Google Scholar]
- 26.You L Toward computational systems biology [Internet]. Vol. 40, Cell Biochemistry and Biophysics. Springer; 2004. [cited 2021 Mar 26]. p. 167–84. Available from: https://link.springer.com/article/10.1385/CBB:40:2:167 [DOI] [PubMed] [Google Scholar]
- 27.Banga JR. Optimization in computational systems biology [Internet]. Vol. 2, BMC Systems Biology. BioMed Central; 2008. [cited 2021 Mar 26]. p. 47. Available from: https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-2-47 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Olofsson S, Mehrian M, Calandra R, Geris L, Deisenroth MP, Misener R. Bayesian Multiobjective Optimisation with Mixed Analytical and Black-Box Functions: Application to Tissue Engineering. IEEE Trans Biomed Eng. 2019. Mar 1;66(3):727–39. [DOI] [PubMed] [Google Scholar]
- 29.Göhl J, Markstedt K, Mark A, Håkansson K, Gatenholm P, Edelvik F. Simulations of 3D bioprinting: Predicting bioprintability of nanofibrillar inks. Biofabrication [Internet]. 2018. Jun 18 [cited 2021 Jul 2];10(3):034105. Available from: 10.1088/1758-5090/aac872 [DOI] [PubMed] [Google Scholar]
- 30.Sun Y, Yang X, Wang Q. In-silico analysis on biofabricating vascular networks using kinetic Monte Carlo simulations. Biofabrication [Internet]. 2014. Mar [cited 2021 Jul 2];6(1). Available from: https://pubmed.ncbi.nlm.nih.gov/24429898/ [DOI] [PubMed] [Google Scholar]
- 31.Bordon J, Moskon M, Zimic N, Mraz M. Fuzzy logic as a computational tool for quantitative modelling of biological systems with uncertain kinetic data. IEEE/ACM Trans Comput Biol Bioinforma [Internet]. 2015. Sep 1 [cited 2021 Mar 26];12(5):1199–205. Available from: https://pubmed.ncbi.nlm.nih.gov/26451831/ [DOI] [PubMed] [Google Scholar]
- 32.Küffner R, Petri T, Windhager L, Zimmer R. Petri Nets with Fuzzy Logic (PNFL): Reverse Engineering and Parametrization. Isalan M, editor. PLoS One [Internet]. 2010Sep 20 [cited 2021 Mar 26];5(9):e12807. Available from: https://dx.plos.org/10.1371/journal.pone.0012807 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Tan TZ, Ng GS, Quek C. A novel biologically and psychologically inspired fuzzy decision support system: Hierarchical complementary learning. IEEE/ACM Trans Comput Biol Bioinforma. 2008. Jan 1;5(1):67–79. [DOI] [PubMed] [Google Scholar]
- 34.Sedigh A, DiPiero D, Shine KM, Tomlinson RE. Enhancing precision in bioprinting utilizing fuzzy systems. Bioprinting. 2022. Mar 1;25:e00190. [Google Scholar]
- 35.Luo ZP, Zhang L, Turner RT, An KN. Effects of mechanical stress/strain and estrogen on cancellous bone structure predicted by fuzzy decision. IEEE Trans Biomed Eng. 2000;47(3):344–51. [DOI] [PubMed] [Google Scholar]
- 36.Optimizing R, Sedigh A, Akbarzadeh-T MR, Tomlinson RE. Optimizing Mineralization of Bioprinted Bone Utilizing Type-2 Fuzzy Systems. Biophys 2022, Vol 2, Pages 400–411 [Internet]. 2022 Oct 28 [cited 2022 Dec 29];2(4):400–11. Available from: https://www.mdpi.com/2673-4125/2/4/35/htm [Google Scholar]
- 37.Rajabi N, Rezaei A, Kharaziha M, Bakhsheshi-Rad HR, Luo H, Ramakrishna S, et al. Recent Advances on Bioprinted Gelatin Methacrylate-Based Hydrogels for Tissue Repair. Tissue Eng - Part A [Internet]. 2021. Jun 1 [cited 2023 Jan 9];27(11–12):679–702. Available from: https://www.liebertpub.com/doi/10.1089/ten.tea.2020.0350 [DOI] [PubMed] [Google Scholar]
- 38.Marcotte M, Hoshahili ART, Ramaswamy HS. Rheological properties of selected hydrocolloids as a function of concentration and temperature. Food Res Int. 2001. Jan 1;34(8):695–703. [Google Scholar]
- 39.Dean A, Voss D, Draguljić D. Response Surface Methodology. 2017. [cited 2022 Dec 29];565–614. Available from: https://link.springer.com/chapter/10.1007/978-3-319-52250-0_16 [Google Scholar]
- 40.Ouyang L, Yao R, Zhao Y, Sun W. Effect of bioink properties on printability and cell viability for 3D bioplotting of embryonic stem cells. Biofabrication [Internet]. 2016. Sep 16 [cited 2022 May 8];8(3):035020. Available from: https://iopscience.iop.org/article/10.1088/1758-5090/8/3/035020 [DOI] [PubMed] [Google Scholar]
- 41.Kim JH, Seol YJ, Ko IK, Kang HW, Lee YK, Yoo JJ, et al. 3D Bioprinted Human Skeletal Muscle Constructs for Muscle Function Restoration. Sci Reports 2018 81 [Internet]. 2018. Aug 17 [cited 2022 Dec 29];8(1):1–15. Available from: https://www.nature.com/articles/s41598-018-29968-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Rossetti T, Nicholls F, Modo M. Intracerebral cell implantation: Preparation and characterization of cell suspensions. Cell Transplant [Internet]. 2016. Apr 1 [cited 2022 Dec 29];25(4):645–64. Available from: https://journals.sagepub.com/doi/10.3727/096368915X690350 [DOI] [PubMed] [Google Scholar]
- 43.Cooke ME, Rosenzweig DH. The rheology of direct and suspended extrusion bioprinting. APL Bioeng [Internet]. 2021. Feb 4 [cited 2022 Dec 29];5(1):011502. Available from: https://aip.scitation.org/doi/abs/10.1063/5.0031475 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.